Pasquale Sansone is a portfolio manager within the healthcare franchise at Candriam, with a specific focus on oncology directed research and investments.
Prior to joining Candriam, Pasquale served as an Oncology Investment Analyst at J. Goldman & Co and previously at Alera Partners, focusing on oncology investments and life sciences opportunities.
He graduated from the University of Bologna and Memorial Sloan-Kettering Cancer Center, US. Prior to his career in finance, Pasquale had spent 14 years as academic cancer researcher in the US.
Discover the latest articles by Pasquale Sansone
Pasquale Sansone, Equities, Healthcare
A decade ago, the idea of detecting cancer from a blood sample, mapping a tumour's genetic profile, or designing a personalised therapy with the help of artificial intelligence sounded futuristic. Today, these advances are moving into clinical practice.